Articles tagged with Antibiotics
Researchers found that steroid nasal sprays combined with antibiotics significantly improved sinusitis symptoms and reduced recovery time. A study of 95 adults with recurrent or chronic sinusitis reported a 93% cure rate using fluticasone, compared to 74% for placebo.
A study suggests that minocycline, a common antibiotic, could be a potential therapy for multiple sclerosis. The drug showed promising results in rats with autoimmune encephalomyelitis, reducing neurologic dysfunction and disease severity.
A global white paper on bacterial resistance in respiratory tract infections calls for concerted international action to tackle the growing threat of antibiotic-resistant bacteria. The initiative aims to implement robust surveillance, education, and patient involvement to control resistance.
Researchers at UCSD and VA San Diego Healthcare System discovered a natural antibiotic peptide called cathelicidin, which inhibits microbe growth and plays a crucial role in mammalian innate immunity. The study provides hope for developing new treatments and a blood test to identify individuals susceptible to bacterial infections.
Scientists have identified a novel family of peptide antibiotics, Piscidins, isolated from the tissues of hybrid striped bass and found in mast cells. These potent compounds show broad-spectrum activity against various bacterial pathogens, including multi-drug-resistant strains.
Researchers from North Carolina State University isolated a new peptide antibiotic from hybrid striped bass mast cells, which could fight important bacterial pathogens in both fish and mammals.
Researchers at Weizmann Institute and Max-Planck Research Units create crystals capturing individual complexes formed between bacterial ribosomes and antibiotics, revealing how these drugs shut off protein production. The findings may improve treatment strategies of existing drugs and lead to rational drug design.
Researchers have identified a subset of genes in Pseudomonas aeruginosa that behave differently when the bacteria exists as a biofilm. These findings may lead to the development of new therapies targeting antibiotic resistance in biofilms. The study found that certain genes were repressed or activated in response to antibiotic treatmen...
Researchers found that 60% of patients received first-line antibiotics and had a 90.1% success rate, while those who received second-line antibiotics had a similar 90.8% success rate but were more expensive.
Researchers found oregano oil to inhibit staphylococcus bacterial growth as effectively as standard antibiotics. A study using mice also showed that oregano oil and carvacrol had promising results against the bacteria.
A large-scale study found that giving erythromycin to newborns within the first two weeks of life increases their risk of developing pyloric stenosis. The researchers used data from over 14,000 babies born between 1993 and 1999.
A new trial found that warming patients before short duration, clean surgery significantly reduced wound infection rates. The study compared warmed and non-warmed groups and found a substantial reduction in infections in the warmed group, with only 5% of patients developing wound infections.
Researchers at Rockefeller University have identified a new model of staph drug resistance that implicates an unlikely protein. The study shows that the mecA gene confers resistance to methicillin and other antibiotics by coding for a different PBP, which is not destroyed by beta-lactam antibiotics.
Researchers at Rockefeller University have discovered that a persistent lineage of Staphylococcus aureus is exceptionally adept at acquiring resistance to antibiotics. This 'Iberian' clone, first identified in 1986, has spread globally and is resistant to multiple antibiotics, posing a significant threat to public health.
Ketek has been granted marketing authorisation by the European Commission for treating community-acquired respiratory tract infections, including those caused by resistant bacteria. The approval follows positive opinion from the Committee for Proprietary Medicinal Products and will be available in all 15 EU-Member States.
A new case of resistance to the antibiotic linezolid has been reported in a patient with MRSA infection, highlighting the need for clinical laboratories to perform susceptibility tests. The finding is rare and has occurred after limited use of the drug, emphasizing the importance of monitoring its effectiveness.
Researchers found that antacids significantly increased the survival rate of Vibrio vulnificus, a bacteria commonly contracted through eating raw oysters. Banning antibiotics in Denmark has also led to significant decreases in resistance rates among food animals.
Researchers used 'gene chips' to analyze the effects of two antibiotics on bacteria, revealing distinct gene signatures that can aid in developing novel antibiotics. This technology helps classify and combat increasingly resistant bacterial strains.
Researchers at Cedars-Sinai Medical Center found that 78% of patients with IBS had excessive bacteria in the small intestine. Treatment with antibiotics reduced symptoms in most patients, suggesting a strong association between SIBO and IBS.
A growing global problem: Bacterial resistance to antibiotics is on the rise, with penicillin and macrolide antibiotics showing high levels of resistance. Telithromycin, a new ketolide antibiotic, has shown promise in combating treatment-resistant respiratory tract infections.
Researchers have identified a link between obesity, digestive system malfunctions, and excessive alcohol production in the liver. Feeding obese mice antibiotics significantly reduced alcohol production, suggesting a potential treatment strategy using oral antibiotics or yogurt to constrain intestinal bacterial overgrowth.
A new clinical score for managing upper respiratory tract infections with sore throat could substantially reduce unnecessary antibiotic prescriptions. The study found that using the score would have reduced antibiotics prescribed to culture-negative patients by 63.7% and overall antibiotics by 52.3%.
A team of researchers has discovered a diverse range of actinomycetes in marine environments, including coral reef sponges and sediments. These bacteria have the potential to produce novel antibiotics and are being explored as a source of future medicines.
A six-month study confirms that antibiotic choice significantly impacts long-term patient outcomes for acute infections, with gemifloxacin reducing hospitalizations and recurrences of chronic bronchitis. The study found a 30% lower rate of recurrence in patients treated with gemifloxacin compared to clarithromycin.
A clinical trial shows that a single dose of Zithromax is as effective as a 10-day course of Augmentin in treating acute otitis media in children. The study found high treatment success rates for both regimens.
Physician and nurse education may not be sufficient to reduce antibiotic overuse; restriction and concurrent review shown to lead to sustained improvement.
The overuse of antibiotics reflects both clinical need and non-clinical factors, including drug companies' advertising campaigns, 'drug hunger,' and a medical system prioritizing productivity. This misuse leads to the development of antibiotic-resistant microbes, posing a significant global threat.
A study published in the Journal of the American Medical Association found that nearly 90% of high-risk patients received antibiotic instructions, while only 60% of moderate-risk patients did. The study also revealed that 25% of low-risk patients incorrectly received antibiotics and 13% chose not to take them.
Researchers create a new type of antibiotics that bind to bacterial protein-making machinery, preventing resistance. The approach could yield an antibiotic approximately 1,000 times more effective than the original, offering hope in combating the growing problem of antibiotic resistance.
Researchers have identified a water extract from potatoes that inhibits the attachment of certain bacteria, such as oral streptococcus and E. coli, to their target tissue. This finding could provide a new direction for antibiotic research and potentially help solve the growing problem of antibiotic resistance.
Researchers at the University of Wisconsin-Madison have designed a new type of molecule that exhibits wide-spectrum antimicrobial activity, including effectiveness against resistant bacteria. The synthetic beta-peptides mimic naturally-occurring peptides found in nature and have shown promise in laboratory tests.
Scientists at the University of Chicago have discovered exactly how beta-lactamase deactivates penicillin, a crucial step in understanding the mechanism of resistance. This breakthrough could lead to improved antibiotic design and help combat hospital-acquired infections caused by resistant bacteria.
Researchers found that two-thirds of unnecessary antibiotic prescriptions were given to patients with negative throat cultures. Inaccurate diagnoses and lack of immediate diagnostic tools contribute to the problem. Experts blame current diagnostic methods and advocate for improved solutions.
A recent NICHD study found that antibiotic treatment for bacterial vaginosis was ineffective in preventing premature birth. The study, which treated over 1,900 pregnant women, showed no significant reduction in preterm births among those receiving metronidazole treatment.
Researchers at Dartmouth Medical School have discovered a way to inhibit the enzyme that many bacteria use to infect and damage hosts. This finding could provide a foundation for developing new agents to combat bacterial infections, potentially leading to therapies against cystic fibrosis and other diseases.
Researchers at Wayne State University have designed two novel antibiotics to combat antibiotic resistance. The 'self-destructive' antibiotic breaks down in the presence of light, while the 'self-regenerating' antibiotic remains effective against resistant bacteria by releasing its active form after encountering resistance enzymes.
A new method for crafting medical implants from an antibacterial polymer could prevent thousands of patients from dying of hospital-acquired infections. The technology slowly releases an antibiotic to keep bacteria from establishing a foothold, making it ideal for catheters and permanent implants.
A study found that 80% of colonic bacteria contain a gene resistant to tetracycline, highlighting rapid spread of resistance genes. The discovery suggests that other resistance genes are also moving along with the tetracycline resistance gene.
New data confirm Relenza's effectiveness in targeting viral replication and reducing complications in patients with influenza B. High concentrations of the drug in the lungs also reduce the risk of resistance development.
A study of 232 rheumatology patients found nearly half used alternative treatments and discussed them with physicians, highlighting the need for physician inquiry. Additionally, a single dose of azithromycin prevents syphilis in exposed individuals, while flu vaccinations benefit HIV-infected patients.
A new study found that treating entire communities with oral antibiotic azithromycin effectively controls an infection causing widespread eye disease. The treatment reduces the number of infections by up to 90% compared to topical therapy, offering a promising solution for controlling trachoma in endemic areas.
A study by Northwestern University researchers finds that linezolid is highly effective against a range of gram-positive bacteria, including those resistant to vancomycin and oxacillin. The antibiotic showed potent activity against all isolates tested, making it a promising new treatment option for patients with drug-resistant infections.
Researchers will investigate whether azithromycin reduces the risk of heart attacks and strokes in people with documented heart disease. A total of 4,000 volunteers will be recruited nationally to participate in the Azithromycin and Coronary Event Study.
Researchers at the University of Toronto have discovered a 50-million-year-old association between an antibiotic-producing bacterium and fungus-growing ants. The study suggests that this symbiotic relationship may provide valuable new insights into the identification, production, and use of antibiotics.
Researchers found that an experimental antibiotic, moxifloxacin, is effective against a range of drug-resistant bacterial strains, including those resistant to penicillin and erythromycin. The findings suggest it could be a potential treatment for serious and deadly illnesses caused by Streptococcus pneumoniae bacteria.
The Azithromycin and Cardiac Events Study (ACES) investigates the role of Chlamydia pneumoniae in atherosclerosis. Researchers aim to determine if antibiotics can prevent complications of coronary artery disease, enrolling approximately 4,000 volunteers.
Despite long-standing guidelines recommending antibiotic prophylaxis for dental patients with cardiac valvular problems, a new study finds no association between dental procedures and the onset of endocarditis. The researchers suggest reconsidering current policies due to low incidence and potential risks associated with antibiotics.
A clinical trial testing Azithromycin's effectiveness in preventing recurrent heart attacks found a promising link between the antibiotic and reduced inflammation. Researchers aim to determine if treating patients with Azithromycin for five days after an initial heart attack can prevent future heart attacks.
A new study reports a significant increase in rheumatic fever cases in the Utah area, with over two-thirds of patients showing no history of sore throat. The disease, which can lead to permanent heart valve damage, is on the rise again, sparking concerns among medical professionals.
A study challenges the widely accepted pediatric practice of prescribing a 10-day course of antibiotics for uncomplicated ear infections, suggesting that five days of short-acting oral antibiotics are equally effective. The researchers found no significant difference in treatment failure rates when comparing the two treatment courses.
Researchers at Scripps Research Institute and R.W. Johnson Pharmaceuticals have developed a new class of antibacterial agents that inhibit two-component signal transduction systems, a key regulatory mechanism in bacterial virulence. These inhibitors show promise as a potential tool against antimicrobial-resistant pathogens.
Primary care physicians are spending more time with their young patients, providing increased preventive services and counseling. The study also found a rise in medication prescriptions, including antibiotics and the stimulant Ritalin, without clear evidence of their appropriateness.
The Resistance Web offers health care professionals and medical researchers immediate access to 10 years of drug resistance tracking data. The site helps alert medical professionals to drug resistance patterns, over-prescribing dangers, and encourages focused surveillance activities.
A recent study found that most common colds are caused by viruses, with rhinovirus being the primary culprit. Researchers identified 138 cases of the common cold in university students, with 105 cases linked to rhinovirus infection.
Researchers at Washington University School of Medicine discovered that E. coli can live inside immune-system cells lining the bladder wall, making it harder to treat bladder infections. The bacteria use sticky appendages to cling to these cells and evade antibiotics.
Researchers at the University of Cincinnati have developed a system to synthesize and screen novel beta-lactam antibiotics, including some effective against extremely low levels of bacteria. The process takes about two days and produces over 1,000 novel compounds with potential for use in antibiotic skin patches.
Researchers create unnatural polyketides with anti-bacterial properties by altering enzyme feedstocks, promising to multiply the power of combinatorial biosynthesis and generate hundreds of new compounds for lead molecule discovery
Research on nematodes led to the discovery of potential anti-cancer drugs and antibiotics. The substances, called xenorxides, have proven more effective than traditional anti-cancer drugs in some test settings.
Researchers have exposed the precise interactions between antibiotics and bacterial ribosomes, revealing a 'lock-and-key' system that sheds light on antibiotic effectiveness and resistance. The study highlights the importance of targeting RNA in cells and provides potential strategies for designing new, less toxic drugs.
A cost-effectiveness analysis suggests that over-the-counter antibiotic treatment for urinary tract infections (UTI) would not be cost-effective in the long run. The study found that the benefits of reduced symptom days would be offset by an increase in treatment costs and potentially lead to increased antibiotic resistance.